Health Care/Hospital

New Cynosure Global Report Reveals Strong Consumer Appetite For Return to In-Office Aesthetic Treatments

"The Return of Aesthetic Patients Post COVID-19" report finds majority of consumers eager to resume treatments and suggests necessary practitioner steps to ensure patient confidence WESTFORD, Massachusetts, June 22, 2020 /PRNewswire/ -- Cynosure, a global leader in medical aesthetics, today unve...

2020-06-22 20:45 1102

Amid Turmoil, 2020 Tang Prize Laureates Strive for An Orderly New World

TAIPEI, Taiwan, June 21, 2020 /PRNewswire/ -- The theme of the 2020 Tang Prize, "for a world of virtue," is intended to extol the pursuit of the ultimate goodness taken up by its latest laureates who demonstrated to us the best one can achieve in the fields of environmental sustainability, medica...

2020-06-21 12:30 1467

Happiness Biotech Announced Progress of COVID-19 Testing Kits

NANPING, China, June 19, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company has obtained the CE Certification for the Company's COVID-19 anti-body testing k...

2020-06-19 20:00 5686

Reistone Announces First Patient Dosed in a Phase II Global Study of SHR0302 JAK Inhibitor for Alopecia Areata

SHANGHAI, June 18, 2020 /PRNewswire/ -- Reistone Biopharma Company Limited (Reistone), a clinical stage biopharmaceutical company focused on developing novel medicines for autoimmune and inflammatory diseases, today announced dosing of the first patient in their Phase II, global clinical trial (R...

2020-06-19 09:16 1245

Kangpu to Present Two Posters at the 2020 American Association for Cancer Research (AACR) Annual Meeting

SHANGHAI, June 17, 2020 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company focused on the discovery and development of next-generation of immunomodulatory small molecules for the treatments of solid tumors, hematological malignancies, auto-immune diseases as well as inflammatory...

2020-06-17 21:00 1641

Immunexpress Awarded BARDA Contract to Develop SeptiCyte® RAPID for COVID-19 Patient Triage

SEATTLE, June 16, 2020 /PRNewswire/ -- Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, has been awarded a grant from the Biomedical Advanced Research and Development Authority ("BARDA"), part of the Office of the Assistant Secretary ...

2020-06-16 20:00 1044

Appian Announces CampusPass™ Solution for Universities

CampusPass™ enables school administrators to coordinate the complexities of returning their community to campus while prioritizing health, safety, and data privacy in the wake of COVID-19 MCLEAN, Virginia, June 15, 2020 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced a new COVID-19 pandemi...

2020-06-15 21:00 6659

Epredia and Lunaphore Announce Commercial Agreement for Exclusive Distribution of LabSat® Research

PORTSMOUTH, New Hampshire and LAUSANNE, Switzerland, June 15, 2020 /PRNewswire/ -- Epredia , a global leader in precision cancer diagnostics and tissue diagnostics, and Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment f...

2020-06-15 20:00 1655

TCEB Hosts a Virtual Conference "Thai Mice and the Post-COVID-19 New Normal" Setting the Stage to Restart Thai Mice with a Changing Landscape

BANGKOK, June 15, 2020 /PRNewswire/ -- In response to the gradual easing of lockdown measures,Thailand Convention and Exhibition Bureau (TCEB) is hosting a virtual conference under the theme "Thai MICE and the Post-COVID-19 New Normal" to reignite and resh...

2020-06-15 20:00 1917

ImmVira Raises $58M in Series B financing

SHENZHEN, China, June 15, 2020 /PRNewswire/ -- Today Immvira Group Company, a biotechnology company focused on the development of new generation oncolytic viruses as potential cancer therapeutics, announces the completion of Series B financing for58 million US dollars. Attracting some of the top ...

2020-06-15 20:00 1329

China issues white paper, sharing experience in COVID-19 fight

BEIJING, June 12, 2020 /PRNewswire/ -- A news report by China.org.cn on China's recently issued white paper "Fighting COVID-19:China in Action":   China recently released a white paper titled "Fighting COVID-19: China in Action." At around 37,000 Chinese characters in length, th...

2020-06-12 21:51 2257

I-Mab and ABL Bio to Present Preclinical Data for Joint Bispecific Antibody Program at the 2020 American Association for Cancer Research Virtual Meeting II

SHANGHAI and GAITHERSBURG, Md., June 12, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, will be presenting preclinical data on a newly developed, novel asset TJ...

2020-06-12 20:00 7086

World's first iLDC enabling ADC drug receives IND clearance by the US FDA

SUZHOU, China, June 11, 2020 /PRNewswire/ -- GeneQuantum Healthcare (GQ) has recently received the US IND approval for its in-house developed next generation antibody drug conjugate (ADC) asset, GQ1001. This isthe world's first site-specific ADC produced using the intelligent ligase-dependent co...

2020-06-11 17:10 1170

Sao Thai Duong JSC launches RT-LAMP KIT to Meet Demands for the Widening of Testing After Easing of Lockdown

HANOI, Vietnam, June 10, 2020 /PRNewswire/ -- Governments around the world have achieved various levels of success in using lockdown and social distancing to stop the spread of the Coronavirus within the community and to deal with the COVID-19 pandemic.According epidemiologists, the easing of a l...

2020-06-11 10:01 1711

PharmAbcine execute an agreement with Thermo Fisher for the development and manufacturing of its next-generation immune checkpoint blockade, PMC-309 for Phase I

DAEJEON, South Korea, June 10, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a strategic partnership with Thermo Fisher Scientific for the development and manufacturing of PMC-309, a next-generation immune checkpoint blockade to treat cancer. Under this agreement, PharmA...

2020-06-11 00:00 946

ChemPartner Makes Additional Investments in Biologics from Research to Manufacturing Capabilities

SHANGHAI, June 10, 2020 /PRNewswire/ -- Shanghai ChemPartner announced the additional investments the company is making into its biologics business unit to further its capabilities and capacity in biologics discovery through development and manufacturing. "ChemPartner has rich experience in prov...

2020-06-10 23:03 1443

CellResearch Corporation - Source of cGMP Umbilical Cord Lining Stem Cells for COVID-19 Related Investigator Initiated Clinical Trials

SINGAPORE, June 10, 2020 /PRNewswire/ -- CellResearch Corporation (CellResearch), a regenerative medicine biotechnology company, is making its cGMP-grade umbilical cord lining stem cell product, CorLiCyte®, available complimentary to any licensed medical institution that is seeking to initiat...

2020-06-10 21:00 1086

Sichuan University, Oxford University launch joint cancer research center

CHENGDU, China, June 10, 2020 /PRNewswire/ -- The University of Oxford and China's Sichuan University have jointly launched a center to bolster research cooperation on gastrointestinal cancer. Representatives from the two sides signed a contract for the Sichuan University-University of Oxford Hu...

2020-06-10 17:29 954

China Eastern Airlines: 200+ Medical Supply Flights to Europe

SHANGHAI, June 10, 2020 /PRNewswire/ -- At 09:09 AM June 5 local time, a China Eastern Airlines (CEA) "passenger to cargo" flight MU7263 took off fromJinan to Milan fully loaded with over 20 tons of supplies. This is CEA's 22nd flight transporting medical equipment directly fromChina to Italy. ...

2020-06-10 14:39 2363

Collaborating in Innovative Medical R&D to combat the pandemic, Alphamab Oncology and Institut Pasteur Shanghai Announce Partnership to Co-develop COVID-19 Neutralizing Antibody

SUZHOU, China, June 9, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Jiangsu Alphamab"), a wholly-owned subsidiary of the Company, has entered a partnership agreement with Institut Pasteur ofShanghai, Chinese Academy of...

2020-06-10 08:40 5923
1 ... 253254255256257258259 ... 277